Cargando…
Urea-based anticancer agents. Exploring 100-years of research with an eye to the future
Suramin was the first urea-based drug to be approved in clinic, and in the following century a number of milestone drugs based on this scaffold were developed. Indeed, urea soon became a privileged scaffold in medicinal chemistry for its capability to establish a peculiar network of drug−target inte...
Autores principales: | Listro, Roberta, Rossino, Giacomo, Piaggi, Federica, Sonekan, Falilat Folasade, Rossi, Daniela, Linciano, Pasquale, Collina, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520293/ https://www.ncbi.nlm.nih.gov/pubmed/36186578 http://dx.doi.org/10.3389/fchem.2022.995351 |
Ejemplares similares
-
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
por: Tesei, Anna, et al.
Publicado: (2022) -
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
por: Rossino, Giacomo, et al.
Publicado: (2023) -
Tackling Antimicrobial Resistance with Small Molecules
Targeting LsrK: Challenges and Opportunities
por: Linciano, Pasquale, et al.
Publicado: (2020) -
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
por: Listro, Roberta, et al.
Publicado: (2020) -
Sigma-1 Receptor Agonists Acting on Aquaporin-Mediated H(2)O(2) Permeability: New Tools for Counteracting Oxidative Stress
por: Pellavio, Giorgia, et al.
Publicado: (2021)